With the invention of vaccines, the number of people vaccinated worldwide has gradually increased. On the other hand, due to the effectiveness of the vaccine and personal physical factors, it is impossible to guarantee that each injection of the vaccine is effective.
Therefore, Trinostat neutralizing antibody rapid test kit was invented to test whether the vaccine injection is effective. This product uses the colloidal gold method to detect neutralizing antibodies in human whole blood, serum or plasma. The detection of neutralizing antibodies is helpful for vaccine development, plasma therapy and immunological research. However, it is worth noting that this test can only be a preliminary test, and the results of other alternative detection methods should be combined when confirming
Features and Benefits
Accurate: Serological detection of neutralizing antibody detection with high accuracy
Easy to manage and read results: no instruments or other equipment are required during the test
Quick detection: The result can be detected within 10 minutes, which can be used for large-scale detection.
No specific storage requirements: room temperature (2-30℃)
- White List
Internal program control is included in the test. The colored lines appearing in the control area (C) are internal program control. It confirms sufficient specimen volume and correct procedure technique.
This kit does not provide control standards; however, it is recommended that positive and negative controls be tested as a good laboratory procedure to confirm the test procedure and verify proper test performance.
Relative Sensitivity, Specificity and Accuracy
The SARS-CoV-2 Neutralizing Antibody Rapid Test (COVID-19 Ab) has been evaluated with specimens obtained from a population of positive and negative specimen. Results were confirmed by a commercial SARS-CoV-2 Neutralization Antibody Detection Kit (ELISA kit, cutoff 30% signal inhibition).
||A commercial SARS-CoV-2 Neutralization Antibody Detection Kit (ELISA kit)
|SARS-CoV-2 Neutralizing Antibody Rapid Test (COVID-19 Ab)
Relative Sensitivity: 96.97%（95%CI：83.35%～99.99%）
Relative Specificity: 100.00%（95%CI：97.29%～100.00%）